Coskuns research contributions include: Preclinical characterization of GLP2s dual receptor agonism and pharmacological properties Elucidation of the complementary mechanisms by which GIP and GLP-1 receptor activation produce synergistic metabolic effects Investigation of GLP2s effects on glucose homeostasis, body weight regulation, and energy expenditure in animal models Development of the scientific rationale supporting GLP2s advancement into human clinical trials Publication of seminal research establishing GLP2s unique pharmacological profile as an imbalanced dual agonist His work has contributed significantly to advancing understanding of incretin biology and establishing GLP2 as the prototype for a new therapeutic class in metabolic disease treatment
If youre having trouble incorporating fiber or protein into your diet, consider talking to a registered dietitian who has experience with type 2 diabetes
What it does require is a bit of planning though
The mitochondrial-targeted derivative of 2,2,6,6-tetramethylpiperidinooxy (TEMPO), Mito-TEMPO, can scavenge excess free radicals produced by mitochondria and is used as a ferroptosis inhibitor to study the occurrence of ferroptosis in mitochondria [123]
Each product we feature has been independently selected and reviewed by our editorial team."
The STEP clinical trials reported larger average percentage weight loss compared with results observed in the SCALE studies
